Assessment of the nutrition status of patients with Huntington's disease.
about
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersAtaxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse modelAltered hypothalamic protein expression in a rat model of Huntington's diseaseMaintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunctionDietary intake in adults at risk for Huntington disease: analysis of PHAROS research participantsEarly energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expressionBody composition in premanifest Huntington's disease reveals lower bone density compared to controlsNo evidence of impaired gastric emptying in early Huntington's Disease.ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice.Volumetric analysis of the hypothalamus in Huntington Disease using 3T MRI: the IMAGE-HD Study.Chromosome substitution strain assessment of a Huntington's disease modifier locusCombined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.High Protein Diet and Huntington's DiseaseProgressive Impairment of Lactate-based Gluconeogenesis in the Huntington's Disease Mouse Model R6/2Cardiac dysfunction in the R6/2 mouse model of Huntington's diseaseA 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.Measures of growth in children at risk for Huntington diseaseEuglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.A Metabolic Study of Huntington's Disease.Metabolic disruption identified in the Huntington's disease transgenic sheep model.Analysis of metabolic effects of menthol on WFS1-deficient mice.Therapeutic perspectives for the treatment of Huntington's disease: treating the whole bodyHypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse modelsAltered lipid metabolism in Drosophila model of Huntington's disease.Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.Energy deficit in Huntington disease: why it matters.The role of IκB kinase complex in the neurobiology of Huntington's disease.Therapy in Huntington's disease: where are we?Clinical value of nutritional status in neurodegenerative diseases: What is its impact and how it affects disease progression and management?Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's diseaseGrowth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease.Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease
P2860
Q24562763-32B94D35-E30F-431F-B553-98948ED47291Q27311213-2644742D-579B-499C-AB19-267BF945B5AEQ27314833-6C5E1D23-87FC-4167-AF11-F66D64231B0CQ27341821-7D1D7FD5-2773-48FE-898F-66838073FF01Q30435217-E34B56A6-6603-4E2A-A4FD-9446829464CBQ33291754-712CB57C-FC04-46C8-9E19-17F6D7D92066Q33755845-FBE6AEC8-7311-4A71-BEC9-9E83E56BE692Q33838303-F979046E-E3AB-4A5A-8EF3-A4010F1DAE55Q34087126-C51571A6-5EB6-4E86-BE8E-14EFDECB21A9Q34407813-6F6DD446-0BE9-4CC0-8B3D-ED4C61E75CE6Q35058349-E25235AE-3F1D-4CA3-B8E6-D30F71DB9906Q35214662-ABAE5B8C-A6AD-4A01-B970-526165DC8F17Q35356604-CDE33415-8F8E-4890-9A95-BF8B1642A150Q35624733-D070E7E9-8AA5-468D-889C-1CB1D5CCF1A2Q35660733-23314FB8-0743-4D25-BAAF-5E79C4D14F18Q35745626-F4EBC45E-464A-482C-BC02-1A96B8281689Q35797126-4230D22E-B447-44F0-B552-0CFAA77B4809Q36149988-0AA2C57F-18EA-4729-AC43-678CBBE68874Q36234711-0E24A6FC-269F-4111-843C-312DA64D6BC3Q36445216-829A62F4-AE92-4063-B80A-BDA9931E827CQ36569413-BD05C8D5-5EAA-4FC5-8AF9-A73C92E3DEC3Q36597744-7E2C79A2-A40B-4D45-BB5B-F07D622E5264Q36999830-F85DA935-16E9-4F4E-A8A8-166BC46D5EC9Q37003956-980432F0-7BE9-4BEE-985A-AF64D2B3441FQ37112122-97DD3C7F-1A01-40DD-9195-F62B1A171737Q37163313-8DFDD3C6-7E67-47E0-934B-0058B417E89EQ37696030-52100E21-84C4-4F15-B934-ECCF8744867FQ37834195-D0F4B427-6F9F-489F-B52D-F59DC9BC8348Q37873608-3DF9866B-DD2D-4A60-BE90-C836BDDB1844Q38006434-14443CAA-72E8-4A1C-8928-4030BD43B9C2Q39024319-06867D9B-EA6E-4602-9BD5-4931E707D3EAQ39629256-00ABE34B-83F6-4C52-B042-DFD52366F4C2Q42577971-39F56E71-EB13-4057-AA59-76E91417905AQ43257519-53D62967-F45D-4AB6-A3A3-C0D2D03E6694Q47304813-0497B714-454A-4173-ABEA-1FC69A946EF7Q48140308-8BB668A4-5858-45A3-8483-916D88559B85Q58041298-A9F01169-030B-4307-A097-3A5D79D66111
P2860
Assessment of the nutrition status of patients with Huntington's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Assessment of the nutrition status of patients with Huntington's disease.
@en
Assessment of the nutrition status of patients with Huntington's disease.
@nl
type
label
Assessment of the nutrition status of patients with Huntington's disease.
@en
Assessment of the nutrition status of patients with Huntington's disease.
@nl
prefLabel
Assessment of the nutrition status of patients with Huntington's disease.
@en
Assessment of the nutrition status of patients with Huntington's disease.
@nl
P2093
P1433
P1476
Assessment of the nutrition status of patients with Huntington's disease
@en
P2093
Adriana Ochoa
Araceli Trejo
Leora Velásquez
Ma Elisa Alonso
Rosa María Tarrats
P304
P356
10.1016/J.NUT.2003.10.007
P577
2004-02-01T00:00:00Z